UBE2D1 and hepatocellular carcinoma: A comprehensive understanding of the molecular mechanisms involved in the regulation of the miR-101/UBE2D1 axis provides new perspectives for the diagnosis and targeted treatment of HCC, suggesting the potential benefit of combining UBE2D1 inhibition with conventional chemotherapy.